Viral Gene Therapy © LABSTER

Viral Gene Therapy: Use DNA to prevent heart failure

Does using viruses as a form of therapy sound like science fiction to you? This may come as a surprise, but it’s actually a technique on the rise used to deliver functional genes into patients. In the Viral Gene Therapy simulation, you will learn about the use of modified viruses and how to equip them with therapeutic genes. Take advantage of the recent exciting research findings in the field, and try to develop a potential cure for heart failure. Will you be able to design a virus that can help to revert heart failure in patients?

At the end of this simulation, you will be able to…

• Explain the use of gene therapy for the treatment of heart failure

• Explain the causes of heart failure

• Design a viralmediated gene therapy approach

• Define “therapeutic gene”

• Describe the anatomy and function of the heart from a healthy person vs. a heart failure patient

• Produce replicationdefective recombinant adenoassociated virus (rAAV)


Techniques In Lab: Co-transfection of mammalian cells | Viral vector production | Electron microscopy

For detailed information please contact:


Merlet Behncke-Braunbeck
Director Distance Learning
Tel.:  +49 (0) 6221 487 8061
E-mail: merlet.braunbeck@springer.com.

Please contact me directly or use the quick & easy
Contact form for corporate customers



Date | Price | Audience


Course: 

Virtual Lab Simulation


Co-operation partner: 

Labster


Time to complete course: 

42 min


Level:

Basic


Price:

please contact Merlet Behncke-Braunbeck


Date:

Start possible at any time


Booking:

Companies can book this course for their employees directly at Springer Campus.


AGB          Back to overview page